Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:52 PM
Ignite Modification Date:
2025-12-24 @ 2:52 PM
NCT ID:
NCT03323359
Eligibility Criteria:
Inclusion Criteria:
* Hepatocellular carcinoma
* Hilar cholangiocarcinoma
* Adrenal cancer metastasis
* Breast cancer metastasis
* Colorectal cancer metastasis
* Ovarian cancer metastasis
* Biliary carcinoma
* Hemangioma
* Hepatic adenoma
* Focal nodular hyperplasia
* Unilocular hydatid cyst
* Multilocular hydatid cyst
Exclusion Criteria:
* Trauma surgery
* Active sepsis around the liver
* Documented history of cirrhosis
* Pregnant or nursing women
* Severe coagulopathy (defined as an International normalized ratio \>2.0)
* Severe Liver disfunction, as per clinical assessment
* Previous liver transplantation
* Laparoscopic procedure
* Any other intraoperative finding, which defines the no eligibility of the patient for liver resection
* Known hypersensitivity to bovine proteins or brilliant blue
* Mental condition rendering the patient unable to understand the nature, scope and possible consequences of the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT03323359
Study Brief:
Protocol Section:
NCT03323359